Your browser doesn't support javascript.
loading
Copy number increase of oncoprotein CIP2A is associated with poor patient survival in human head and neck squamous cell carcinoma.
Routila, Johannes; Bilgen, Türker; Saramäki, Outi; Grénman, Reidar; Visakorpi, Tapio; Westermarck, Jukka; Ventelä, Sami.
  • Routila J; Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, Finland.
  • Bilgen T; Prostate Cancer Research Center, Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland.
  • Saramäki O; Research and Application Centre for Scientific and Technological Investigations (NABILTEM), Namik Kemal University, Tekirdag, Turkey.
  • Grénman R; Prostate Cancer Research Center, Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland.
  • Visakorpi T; Fimlab Laboratories, Tampere University Hospital, Tampere, Finland.
  • Westermarck J; Department of Otorhinolaryngology - Head and Neck Surgery, Turku University Hospital, Turku, Finland.
  • Ventelä S; Prostate Cancer Research Center, Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere, Tampere, Finland.
J Oral Pathol Med ; 45(5): 329-37, 2016 May.
Article en En | MEDLINE | ID: mdl-26436875

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoantígenos / Carcinoma de Células Escamosas / Neoplasias de Cabeza y Cuello / Proteínas de la Membrana Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Autoantígenos / Carcinoma de Células Escamosas / Neoplasias de Cabeza y Cuello / Proteínas de la Membrana Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article